For this section, we will initiate discussion of the molecular pathologies by examining the hypothesized role of genetic polymorphisms with established associations with depression (e.g., dopamine D2 receptor, GR, and BDNF). This evidence concerns the gene DRD2 and depressive symptom measurement.